US EditionKELYNIAM ACHIEVES RECORD REVENUE & PROFITABILITY FOR 2024
- Kelyniam Global , a manufacturer of custom cranial implants, announced its financial results for the year ended December 31, 2024, on March 17, 2025, in CANTON, Conn.
- Kelyniam works directly with surgeons, health systems, and payors, aiming to improve clinical and cost-of-care outcomes, and completed an FDA audit late last year which resulted in 5 minor observations.
- Kelyniam's total revenue increased by 24.6% to $3,328,382 for the year ended December 31, 2024, compared to $2,672,357 in 2023, with operating income improving by $515,203 to $277,037 and EBITDA reflecting an earnings/cash contribution of $512,582 to $322,824.
- CEO Ross Bjella stated that 2024 marked the strongest performance in Kelyniam's history.
- Kelyniam will significantly invest in sales and business development activities in 2025, building on the success of 2024 and strengthening relationships with current partners, while also in-licensing products and pursuing organic growth.
Insights by Ground AI
Does this summary seem wrong?
61 Articles
61 Articles
All
Left
4
Center
22
Right
4
Coverage Details
Total News Sources61
Leaning Left4Leaning Right4Center22Last UpdatedBias Distribution73% Center
Bias Distribution
- 73% of the sources are Center
73% Center
13%
C 73%
13%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
